Syringe pickup, pharma deal, commercial rights.
Medical technology company BD, in Franklin Lakes, announced Wednesday the completion of its acquisition of Safety Syringes Inc., of California. Terms were not disclosed.
NovaDel Pharma Inc., of Bridgewater, on Wednesday announced a preliminary agreement to sell its NovaMist technology to SUDA LTD, an Australian pharmaceutical company. Terms were not disclosed.
Princeton-based Soligenix Inc., a development stage biopharmaceutical company, today announced it has regained the North American and European commercial rights to its oral BDP treatment through an amendment of an agreement with Sigma-Tau Pharmaceuticals Inc.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy